ATE289309T1 - Neue cyclohexenyl-phenyl diazepine als vasopressin- und oxytocin-rezeptormodulatoren - Google Patents

Neue cyclohexenyl-phenyl diazepine als vasopressin- und oxytocin-rezeptormodulatoren

Info

Publication number: ATE289309T1
Authority: AT; Austria
Prior art keywords: disorders; treating; oxytocin; diazepines; vasopressin
Prior art date: 2001-04-12

Application number

AT02728749T

Other languages

English (en)

Inventor

Amedeo Arturo Failli

William Jennings Sanders

Eugene John Trybulski

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-12

Filing date

2002-04-11

Publication date

2005-03-15

2002-04-11 Application filed by Wyeth Corp filed Critical Wyeth Corp

2005-03-15 Application granted granted Critical

2005-03-15 Publication of ATE289309T1 publication Critical patent/ATE289309T1/de

Links

-1 CYCLOHEXENYL-PHENYL DIAZEPINES Chemical class 0.000 title 1
102000004279 Oxytocin receptors Human genes 0.000 title 1
108090000876 Oxytocin receptors Proteins 0.000 title 1
GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 title 1
102000004136 Vasopressin Receptors Human genes 0.000 title 1
108090000643 Vasopressin Receptors Proteins 0.000 title 1
KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 title 1
229960003726 vasopressin Drugs 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
208000035475 disorder Diseases 0.000 abstract 3
208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 2
230000002708 enhancing effect Effects 0.000 abstract 2
206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
206010053567 Coagulopathies Diseases 0.000 abstract 1
208000005171 Dysmenorrhea Diseases 0.000 abstract 1
206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
208000004145 Endometritis Diseases 0.000 abstract 1
208000008967 Enuresis Diseases 0.000 abstract 1
206010019280 Heart failures Diseases 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 abstract 1
101800000989 Oxytocin Proteins 0.000 abstract 1
102100031951 Oxytocin-neurophysin 1 Human genes 0.000 abstract 1
208000006399 Premature Obstetric Labor Diseases 0.000 abstract 1
206010046543 Urinary incontinence Diseases 0.000 abstract 1
206010047139 Vasoconstriction Diseases 0.000 abstract 1
102100026383 Vasopressin-neurophysin 2-copeptin Human genes 0.000 abstract 1
230000000740 bleeding effect Effects 0.000 abstract 1
208000015294 blood coagulation disease Diseases 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
230000009852 coagulant defect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010064 diabetes insipidus Diseases 0.000 abstract 1
125000002576 diazepinyl group Chemical class N1N=C(C=CC=C1)* 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000012173 estrus Effects 0.000 abstract 1
230000035558 fertility Effects 0.000 abstract 1
208000031169 hemorrhagic disease Diseases 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000027939 micturition Effects 0.000 abstract 1
206010029446 nocturia Diseases 0.000 abstract 1
208000005346 nocturnal enuresis Diseases 0.000 abstract 1
XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 abstract 1
229960001723 oxytocin Drugs 0.000 abstract 1
239000003336 oxytocin antagonist Substances 0.000 abstract 1
229940121361 oxytocin antagonists Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000001629 suppression Effects 0.000 abstract 1
230000004083 survival effect Effects 0.000 abstract 1
230000002792 vascular Effects 0.000 abstract 1
230000025033 vasoconstriction Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT02728749T 2001-04-12 2002-04-11 Neue cyclohexenyl-phenyl diazepine als vasopressin- und oxytocin-rezeptormodulatoren ATE289309T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28326501P	2001-04-12	2001-04-12
PCT/US2002/011531 WO2002083681A1 (en)	2001-04-12	2002-04-11	Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators

Publications (1)

Publication Number	Publication Date
ATE289309T1 true ATE289309T1 (de)	2005-03-15

Family

ID=23085256

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02728749T ATE289309T1 (de)	2001-04-12	2002-04-11	Neue cyclohexenyl-phenyl diazepine als vasopressin- und oxytocin-rezeptormodulatoren

Country Status (12)

Country	Link
US (1)	US7022699B2 (de)
EP (1)	EP1377584B1 (de)
JP (1)	JP2004530671A (de)
CN (1)	CN1501935A (de)
AT (1)	ATE289309T1 (de)
BR (1)	BR0208940A (de)
CA (1)	CA2443565A1 (de)
DE (1)	DE60203000T2 (de)
DK (1)	DK1377584T3 (de)
ES (1)	ES2236511T3 (de)
MX (1)	MXPA03009335A (de)
WO (1)	WO2002083681A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7202239B2 (en) *	2001-04-12	2007-04-10	Wyeth	Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7109193B2 (en) *	2001-04-12	2006-09-19	Wyeth	Tricyclic diazepines tocolytic oxytocin receptor antagonists
US6900200B2 (en) *	2001-04-12	2005-05-31	Wyeth	Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7064120B2 (en) *	2001-04-12	2006-06-20	Wyeth	Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US6977254B2 (en)	2001-04-12	2005-12-20	Wyeth	Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6903087B2 (en)	2001-04-12	2005-06-07	Wyeth	Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7326700B2 (en) *	2001-04-12	2008-02-05	Wyeth	Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
GB0210397D0 (en)	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
CN102746229B (zh) *	2005-09-02	2015-04-08	大塚制药株式会社	制备苯并氮杂*化合物或其盐的方法
US8399410B2 (en)	2007-08-06	2013-03-19	Allergan, Inc.	Methods and devices for desmopressin drug delivery
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
DK3085381T3 (en) *	2008-05-21	2018-05-28	Ferring Bv	ORODISPERSIBLE DESMOPRESSIN TO INCREASE THE INITIAL PERIOD OF SLEEP UNDERSTANDED BY NEW TURRY
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
MX2011004575A (es)	2008-11-13	2011-06-01	Hoffmann La Roche	Espiro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo [e] azulenos.
SI2358714T1 (sl)	2008-11-18	2012-11-30	Hoffmann La Roche	Alkilcikloheksiletri dihidrotetraazabenzoazulenov
NZ592076A (en)	2008-11-28	2012-06-29	Hoffmann La Roche	Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
PL2376556T3 (pl) *	2008-12-12	2017-05-31	Trinseo Europe Gmbh	Kompozycje kauczukowe modyfikowane olejem
US8420633B2 (en)	2010-03-31	2013-04-16	Hoffmann-La Roche Inc.	Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en)	2010-04-13	2013-06-11	Hoffmann-La Roche Inc.	Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en)	2010-04-21	2013-07-23	Hoffmann-La Roche Inc.	Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en)	2010-04-26	2013-07-09	Hoffmann-La Roche Inc.	Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en)	2010-05-10	2013-08-20	Hoffmann-La Roche Inc.	Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
CN105849086B (zh)	2012-11-24	2018-07-31	杭州多禧生物科技有限公司	亲水性链接体及其在药物分子和细胞结合分子共轭反应上的应用
DK3122757T3 (da)	2014-02-28	2023-10-09	Hangzhou Dac Biotech Co Ltd	Ladede linkere og anvendelse deraf til konjugering
EP3226688B1 (de) *	2014-12-05	2020-07-01	Merck Sharp & Dohme Corp.	Tricyclische verbindungen als inhibitoren von mutanten idh-enzymen
WO2016089833A1 (en) *	2014-12-05	2016-06-09	Merck Sharp & Dohme Corp.	Novel tricyclic compounds as inhibitors of mutant idh enzymes
US10508108B2 (en)	2014-12-05	2019-12-17	Merck Sharp & Dohme Corp.	Tricyclic compounds as inhibitors of mutant IDH enzymes
CN108026123B (zh)	2015-06-15	2021-02-05	杭州多禧生物科技有限公司	用于偶联的亲水链接体
FI3319936T3 (fi)	2015-07-12	2026-03-12	Hangzhou Dac Biotech Co Ltd	Silloituslinkkereitä soluun sitoutuvien molekyylien konjugoimiseksi
US9839687B2 (en)	2015-07-15	2017-12-12	Suzhou M-Conj Biotech Co., Ltd.	Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR20220147721A (ko)	2016-11-14	2022-11-03	항저우 디에이씨 바이오테크 씨오, 엘티디	결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
JP2024541058A (ja)	2021-11-03	2024-11-06	ハンジョウディーエーシーバイオテックシーオー．，エルティディ．	抗体の特異的共役

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4766108A (en)	1986-12-04	1988-08-23	Smith Kline Beckman Corporation	Tyr-Arg-vasopressin antagonists
US5055448A (en)	1987-06-25	1991-10-08	Medical College Of Ohio	Linear derivatives of arginine vasopressin antagonists
DE69009785T2 (de)	1989-02-10	1994-11-03	Otsuka Pharma Co Ltd	Carbostyrilderivate.
US5258510A (en)	1989-10-20	1993-11-02	Otsuka Pharma Co Ltd	Benzoheterocyclic compounds
ES2089033T3 (es)	1989-10-20	1996-10-01	Otsuka Pharma Co Ltd	Compuestos benzoheterociclicos.
US5070187A (en)	1989-11-03	1991-12-03	Trustees Of Boston University	Pharmacologically effective antagonists of arginine-vasopressin
TW199153B (de)	1990-08-07	1993-02-01	Dtsuka Seiyaku Kk
US5459131A (en)	1991-03-15	1995-10-17	American Cyanamid Company	Renin inhibitors
TW198715B (de)	1991-04-19	1993-01-21	Dtsuka Seiyaku Kk
EP0533242A3 (en)	1991-09-16	1993-09-15	Merck & Co. Inc.	Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533240A3 (en)	1991-09-16	1993-09-29	Merck & Co. Inc.	Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
DE69223573D1 (de)	1991-09-16	1998-01-29	Merck & Co Inc	Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten
US5204349A (en)	1991-09-16	1993-04-20	Merck & Co., Inc.	Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
JP2904993B2 (ja)	1991-10-09	1999-06-14	ロート製薬株式会社	オキシトシン受容体およびこれをコードするｄｎａ
FR2687669B1 (fr)	1992-02-24	1997-12-19	Guerbet Sa	Composes utilisables dans des produits de contraste pour la radiographie.
WO1994001113A1 (en)	1992-07-02	1994-01-20	Otsuka Pharmaceutical Company, Limited	Oxytocin antagonist
WO1994004525A1 (en)	1992-08-20	1994-03-03	Otsuka Pharmaceutical Company, Limited	Benzoheterocyclic compounds as oxytocin and vasopressin antagonists
TW270927B (de)	1992-10-16	1996-02-21	Otsuka Pharma Co Ltd
AU5533894A (en)	1992-11-25	1994-06-22	Yamanouchi Pharmaceutical Co., Ltd.	Benzanilide derivative
AU5692094A (en)	1992-12-21	1994-07-19	Yamanouchi Pharmaceutical Co., Ltd.	Novel n-(pyridylcarbonyl)benzazepine derivative and intermediate therefor
WO1994020473A1 (fr)	1993-03-11	1994-09-15	Yamanouchi Pharmaceutical Co., Ltd.	Compose avec action antagoniste de la vasopressine
GB9307527D0 (en)	1993-04-13	1993-06-02	Fujisawa Pharmaceutical Co	New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
EP0714299B1 (de)	1993-07-16	2002-04-24	Merck & Co. Inc.	Benzoxazinon- und Benzopyrimidinon- piperidinyl-Verbindungen als tokolytische Oxytocin-Rezeptor-Antagonisten
US5736540A (en) *	1993-07-29	1998-04-07	American Cyanamid Company	Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5512563A (en)	1993-07-29	1996-04-30	American Cyanamid Company	Tricyclic benzazepine vasopressin antagonists
US5516774A (en)	1993-07-29	1996-05-14	American Cyanamid Company	Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5968930A (en) *	1993-07-29	1999-10-19	American Cyanamid Company	Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5670509A (en)	1993-09-27	1997-09-23	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
US5464788A (en)	1994-03-24	1995-11-07	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
US5436333A (en)	1994-08-08	1995-07-25	American Cyanamid Company	Process for the preparation of tricyclic-heterocycles
US5599809A (en)	1994-09-29	1997-02-04	Merck & Co., Inc.	Method for improving reproductive efficiency in farm animals
US5696112A (en)	1995-01-17	1997-12-09	American Cyanamid Company	Fused heterocyclic azepines as vasopressin antagonists
US5532235A (en)	1995-01-17	1996-07-02	American Cyanamid Company	Tricyclic benzazepine vasopressin antagonists
AR002459A1 (es)	1995-01-17	1998-03-25	American Cyanamid Co	Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
US5849735A (en)	1995-01-17	1998-12-15	American Cyanamid Company	Tricyclic benzazepine vasopressin antagonists
US5521173A (en)	1995-01-17	1996-05-28	American Home Products Corporation	Tricyclic benzazepine vasopressin antagonists
US5536718A (en)	1995-01-17	1996-07-16	American Cyanamid Company	Tricyclic benzazepine vasopressin antagonists
CA2210138A1 (en)	1995-01-24	1996-08-01	Peter D. Williams	Tocolytic oxytocin receptor antagonists
US5726172A (en)	1996-01-16	1998-03-10	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
WO1997025992A1 (en)	1996-01-16	1997-07-24	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
US5756497A (en)	1996-03-01	1998-05-26	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
BR9713253A (pt)	1996-11-01	1999-11-03	American Home Prod	Derivados de 3-carboxamida de 5h-pirrol [2,1-c][1,4]-benzodiazepinas
US5880122A (en)	1996-11-01	1999-03-09	American Home Products Corporation	3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines
AR011913A1 (es)	1997-03-06	2000-09-13	Yamano Masaki	Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
GB2326639A (en)	1997-06-18	1998-12-30	Merck & Co Inc	Piperazine Oxytocin Receptor Antagonists
GB2326410A (en)	1997-06-18	1998-12-23	Merck & Co Inc	Tocolytic Oxytocin Receptor Antagonists
DE69826487T2 (de)	1997-07-30	2005-12-01	Wyeth	Trizyclische vasopressin-agonisten
DE19748763A1 (de)	1997-11-05	1999-05-06	Hans Peter Zenner	Verwendung von Vasopressin-Antagonisten
EP1050308A4 (de)	1998-01-28	2002-09-04	Senju Pharma Co	Präventiva oder mittel gegen visuelle erkrankungen
US7326700B2 (en) *	2001-04-12	2008-02-05	Wyeth	Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6903087B2 (en) *	2001-04-12	2005-06-07	Wyeth	Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7064120B2 (en) *	2001-04-12	2006-06-20	Wyeth	Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US6977254B2 (en) *	2001-04-12	2005-12-20	Wyeth	Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6900200B2 (en) *	2001-04-12	2005-05-31	Wyeth	Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7202239B2 (en) *	2001-04-12	2007-04-10	Wyeth	Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7109193B2 (en) *	2001-04-12	2006-09-19	Wyeth	Tricyclic diazepines tocolytic oxytocin receptor antagonists

2002
- 2002-04-10 US US10/119,611 patent/US7022699B2/en not_active Expired - Fee Related
- 2002-04-11 MX MXPA03009335A patent/MXPA03009335A/es unknown
- 2002-04-11 BR BR0208940-8A patent/BR0208940A/pt not_active IP Right Cessation
- 2002-04-11 CN CNA028080467A patent/CN1501935A/zh active Pending
- 2002-04-11 CA CA002443565A patent/CA2443565A1/en not_active Abandoned
- 2002-04-11 DK DK02728749T patent/DK1377584T3/da active
- 2002-04-11 WO PCT/US2002/011531 patent/WO2002083681A1/en not_active Ceased
- 2002-04-11 JP JP2002581436A patent/JP2004530671A/ja active Pending
- 2002-04-11 EP EP02728749A patent/EP1377584B1/de not_active Expired - Lifetime
- 2002-04-11 ES ES02728749T patent/ES2236511T3/es not_active Expired - Lifetime
- 2002-04-11 DE DE60203000T patent/DE60203000T2/de not_active Expired - Fee Related
- 2002-04-11 AT AT02728749T patent/ATE289309T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK1377584T3 (da)	2005-05-23
DE60203000T2 (de)	2006-03-23
MXPA03009335A (es)	2005-10-05
JP2004530671A (ja)	2004-10-07
US20020198196A1 (en)	2002-12-26
EP1377584B1 (de)	2005-02-16
ES2236511T3 (es)	2005-07-16
WO2002083681A1 (en)	2002-10-24
CA2443565A1 (en)	2002-10-24
EP1377584A1 (de)	2004-01-07
BR0208940A (pt)	2004-04-27
CN1501935A (zh)	2004-06-02
US7022699B2 (en)	2006-04-04
DE60203000D1 (de)	2005-03-24

Legal Events

Date	Code	Title	Description
2005-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE289309T1 (de)	2005-03-15	Neue cyclohexenyl-phenyl diazepine als vasopressin- und oxytocin-rezeptormodulatoren
ES2260434T3 (es)	2006-11-01	Diacepinas triciclicas como antagonistas tocoliticos del receptor de oxitocina.
EP1765362A4 (de)	2010-02-24	Zusammensetzungen und verfahren zur behandlung von neovaskulären erkrankungen
AP1503A (en)	2005-12-24	Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
MA31442B1 (fr)	2010-06-01	3-(imidazolyl)-pyrazolo [3,4-b]pyridines
CR9389A (es)	2007-12-07	Compuestos de imidazopiridazina
BR0012411A (pt)	2002-04-16	Compostos agonistas e antagonistas de serotonina, composição farmacêutica e usos dos compostos
MXPA04000372A (es)	2004-07-23	Compuesto biciclicos de heteroarilo fusionados sustituidos con heteroarilo como ligandos del receptor gabaa.
WO2004098589A8 (en)	2005-12-08	4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
MX2012004848A (es)	2012-05-29	Compuestos heterociclicos triciclicos.
DE60207224D1 (de)	2005-12-15	Neue 10-cyclohexenyl-phenyl-pyrrolobenzodiazepin-3-carboxamide und derivate davon; tokolytische oxytocin-rezeptor-antagonisten
BRPI0409369A (pt)	2006-04-25	derivados de 2-azabiciclo[3.3.1]nonano como antagonistas do receptor opióide
DE60206898D1 (de)	2005-12-01	Neue pyridin- und cyclohexenyl-enthaltende pyrrolobenzodiazepin-carboxamide und derivative davon; tokolytische oxytocin-rezeptor-antagonisten
DE69826677D1 (de)	2004-11-04	Trizyclische vasopressin agoniste
WO2000046224A3 (en)	2000-12-07	Tricyclic pyridine n-oxides vasopressin agonists
WO2006018708A3 (en)	2006-04-20	Pyrrolidine derivatives as muscarinic receptor antagonists
Schulze et al.	2012	Molecular combination of the dopamine and serotonin scaffolds yield in novel antipsychotic drug candidates–characterization by in vivo experiments
ATE419246T1 (de)	2009-01-15	Als antagonisten des muscarinrezeptors geeignete xanthinderivate
WO2023183776A3 (en)	2023-11-02	Targeting sucnr1 to reduce neuroinflammation
Holub et al.	2009	Nerve growth factor activation of the p-38 apoptotic pathway in p-75 transfected SK-N-SH neuroblastoma cells